Equities

Fonar Corp

Fonar Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)17.55
  • Today's Change0.150 / 0.86%
  • Shares traded13.35k
  • 1 Year change+9.55%
  • Beta1.1908
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

FONAR Corporation is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging scanners, MRI, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company conducts its business in two segments. The medical equipment segment is conducted directly through FONAR. The physician management and diagnostic services segment is conducted through its subsidiary Health Management Corporation of America (HMCA). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing, information technology (IT) services, hiring, conducting interviews and managing personnel, storage of medical records, office space, equipment, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging.

  • Revenue in USD (TTM)102.72m
  • Net income in USD10.29m
  • Incorporated1978
  • Employees561.00
  • Location
    Fonar Corp110 Marcus DrMELVILLE 11747-4228United StatesUSA
  • Phone+1 (631) 694-2929
  • Fax+1 (631) 753-5150
  • Websitehttp://www.fonar.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
DIH Holding US Inc67.62m-6.14m84.74m192.00------1.25-0.1903-0.19031.96-0.98411.994.1211.80352,161.50-18.09------48.86---9.09--0.4221-3.38----19.26---732.64------
Pro-Dex Inc53.84m2.13m89.69m148.0043.942.9127.291.670.60790.607915.219.181.032.504.52363,810.804.0812.335.2015.3027.0231.263.9512.131.661.580.27840.0016.8314.66-69.93-12.47-6.80--
Monogram Technologies Inc365.00k-11.69m90.03m28.00--12.77--246.67-0.3745-0.37450.01180.22240.0239----13,035.71-76.61-119.26-117.14-257.400.00---3,203.87-5,045.60----0.00-------0.3964---15.97--
Sensus Healthcare Inc36.37m6.65m95.06m35.0014.251.8013.852.610.40720.40722.233.230.66011.102.651,039,057.0012.0610.2913.2512.1460.2362.8518.2715.298.20--0.00---45.20-1.58-98.00---23.16--
Xtant Medical Holdings Inc110.94m-3.33m97.44m207.00--2.03170.360.8783-0.0284-0.02840.84310.34541.381.406.35535,956.50-4.15-10.38-5.77-14.6861.6161.08-3.00-8.661.01-4.540.429--57.504.81107.78--18.47--
Edap Tms SA (ADR)69.26m-21.95m113.18m307.00--2.13--1.63-0.592-0.5921.871.430.69922.373.42225,598.80-22.16-6.62-31.50-9.2240.3443.23-31.69-9.591.80--0.0599--9.649.05-622.06--32.75--
Cibus Inc2.96m-291.86m116.51m183.00--0.3403--39.35-16.39-16.390.154511.750.0043--3.0916,180.33-53.70-86.28-64.26-96.45-----12,400.74-792.07---2.660.0032--1,057.3350.41-1,484.44--18.53--
Myomo Inc21.11m-9.45m117.58m101.00--12.14--5.57-0.2614-0.26140.58330.32041.433.5010.13209,020.40-64.07-81.78-101.11-115.2767.3568.50-44.75-85.761.94--0.00--23.7051.0924.00--2.82--
Fonar Corp102.72m10.29m117.77m561.0011.850.71066.241.151.481.4814.7224.700.502319.991.41183,098.207.168.737.409.6045.5548.3314.2616.399.16--0.0051--1.083.89-24.71-15.058.48--
Harvard Bioscience, Inc.101.13m-10.68m119.93m391.00--1.78--1.19-0.2471-0.24712.351.540.74411.646.88258,631.70-7.86-3.29-9.44-3.8958.3956.67-10.56-4.570.9416-1.310.3467---0.9573-1.4564.11--18.10--
KORU Medical Systems Inc30.82m-11.76m123.35m82.00--6.59--4.00-0.2574-0.25740.67420.40820.97372.946.50375,817.30-37.15-17.60-43.48-20.2962.4959.44-38.16-21.703.27--0.0195--2.2310.44-58.65--11.10--
EUDA Health Holdings Ltd3.71m-8.44m126.46m106.00------34.12-0.3685-0.43840.1707-0.30450.2752--3.5534,966.61-62.62------22.72---227.57-----1.49-----1.54--66.17------
908 Devices Inc.52.69m-37.99m127.54m230.00--0.8151--2.42-1.15-1.151.604.520.25111.544.95229,069.60-18.11-14.16-20.12-15.3552.3253.02-72.10-64.254.23--0.00--7.2117.89-8.45--22.98--
InfuSystem Holdings Inc129.37m366.00k137.70m499.00412.522.5710.991.060.01570.01575.992.511.2210.386.44259,264.500.34654.600.4015.6949.6856.430.28294.071.641.970.38980.0014.4413.384,744.44--6.01--
Akoya Biosciences Inc93.22m-60.35m142.56m330.00--6.40--1.53-1.22-1.221.890.44980.56051.936.34282,472.70-36.29---45.98--57.57---64.74--1.98-8.000.7755--29.09--10.36------
Data as of Sep 20 2024. Currency figures normalised to Fonar Corp's reporting currency: US Dollar USD

Institutional shareholders

40.01%Per cent of shares held by top holders
HolderShares% Held
Kayne Anderson Rudnick Investment Management LLCas of 31 Mar 2024602.14k9.52%
The Vanguard Group, Inc.as of 31 Mar 2024388.04k6.13%
Dimensional Fund Advisors LPas of 30 Jun 2024365.09k5.77%
Money Concepts Capital Corp.as of 30 Jun 2024362.45k5.73%
Renaissance Technologies LLCas of 30 Jun 2024344.22k5.44%
Acuitas Investments LLCas of 30 Jun 2024113.40k1.79%
LSV Asset Managementas of 30 Jun 2024111.70k1.77%
BlackRock Fund Advisorsas of 31 Mar 202490.27k1.43%
Bridgeway Capital Management LLCas of 31 Mar 202480.29k1.27%
Brandywine Global Investment Management LLCas of 31 Mar 202474.18k1.17%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.